This suggests that elevated levels of bisecting GlcNAc occur early in Alzheimer’s disease pathogenesis, even prior to amyloid/tau abnormality, as it can predict cognitive decline already at an amyloid-/tau-negative stage. Here, MAPT is linked to Alzheimer disease.